Maha Nasr

5.2k total citations
147 papers, 4.2k citations indexed

About

Maha Nasr is a scholar working on Pharmaceutical Science, Molecular Biology and Dermatology. According to data from OpenAlex, Maha Nasr has authored 147 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Pharmaceutical Science, 35 papers in Molecular Biology and 34 papers in Dermatology. Recurrent topics in Maha Nasr's work include Advancements in Transdermal Drug Delivery (45 papers), Advanced Drug Delivery Systems (18 papers) and Dermatology and Skin Diseases (15 papers). Maha Nasr is often cited by papers focused on Advancements in Transdermal Drug Delivery (45 papers), Advanced Drug Delivery Systems (18 papers) and Dermatology and Skin Diseases (15 papers). Maha Nasr collaborates with scholars based in Egypt, Jordan and United Kingdom. Maha Nasr's co-authors include Omaima A. Sammour, Nahed D. Mortada, Samar Mansour, Riham I. El-Gogary, Noha H. Moftah, Sameh Abdel-Hamid, Maha Fadel, Rania M. Hathout, Seham A. Elkheshen and Gehanne A.S. Awad and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Controlled Release.

In The Last Decade

Maha Nasr

142 papers receiving 4.1k citations

Peers

Countries citing papers authored by Maha Nasr

Since Specialization

Citations

This map shows the geographic impact of Maha Nasr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maha Nasr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maha Nasr more than expected).

Fields of papers citing papers by Maha Nasr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maha Nasr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maha Nasr. The network helps show where Maha Nasr may publish in the future.

Co-authorship network of co-authors of Maha Nasr

This figure shows the co-authorship network connecting the top 25 collaborators of Maha Nasr. A scholar is included among the top collaborators of Maha Nasr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maha Nasr. Maha Nasr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Folic Acid-Decorated Lipidic Nanocapsules Co-Loaded with Atorvastatin and Curcumin to Enhance Glioma Targeting in Mice 2025 ·Pharmaceuticals ·(unknown), (unknown), (unknown), Sara A. Abdel Gaber, Mona G. Arafa, Maha Nasr, Omaima A. Sammour	0
2	Gastroprotective Chitosan Nanoparticles Loaded with Oleuropein: An In Vivo Proof of Concept 2024 ·Pharmaceutics ·Hend Abd-Allah, (unknown), Gehad A. Abdel Jaleel, Azza Hassan, (unknown), Maha Nasr	6
3	Assessment of Mesiobuccal Root Canal Curvature in Maxillary Molars of Egyptian Population: A Standardized CBCT-Based Radiographic Protocol 2024 ·(unknown), (unknown), Maha Nasr	1
4	Hibiscus schizopetalus boosts wound healing via restoring redox balance and hindering inflammatory responses in rats: Insights on metabolome profiling and molecular docking 2024 ·Archiv der Pharmazie ·Mariam I. Gamal El‐Din, Eman M. Mantawy, Riham S. Said, Nouran M. Fahmy, Shaimaa Fayez, (unknown), Maha Nasr, Ahmed M. Elissawy, Abdel Nasser B. Singab	0
5	Tailored green synthesized silymarin-selenium nanoparticles: Topical nanocarrier of promising antileishmanial activity 2024 ·International Journal of Pharmaceutics ·(unknown), Mai Mansour, Maha Nasr, Omaima A. Sammour	1
6	Advancements in current one-size-fits-all therapies compared to future treatment innovations for better improved chemotherapeutic outcomes: a step-toward personalized medicine 2024 ·Current Medical Research and Opinion ·Nadia Μ. Hamdy, Emad B. Basalious, (unknown), Maha Nasr, Amany A.E. Ahmed, Eman S. Nossier, Alireza Abadi	40
7	Enhancing the anticancer effect of metformin through nanoencapsulation: Apoptotic induction, inflammatory reduction, and suppression of cell migration in colorectal cancer cells 2024 ·Archiv der Pharmazie ·(unknown), Maha Nasr, (unknown), Mona A.M. Abo-Zeid, Sherien M. El‐Daly	2
8	Antimicrobial photodynamic inactivation and photosensitizers: A succinct review 2024 ·(unknown), Maha Fadel, Maha Nasr	0
9	Development and in Vitro/In Vivo Evaluation of Itopride Hydrochloride Expanding Tablets 2023 ·Journal of Pharmaceutical Innovation ·Walaa Magdy Ahmed, Riham I. El-Gogary, Maha Nasr, Omaima A. Sammour	2
10	Silymarin chitosan-modified penetration enhancer microvesicles as a promising wound healing tool 2023 ·Journal of Drug Delivery Science and Technology ·(unknown), Abdelkader A. Metwally, Maha Nasr	9
11	Curcumin-resveratrol nano-formulation counteracting hyperammonemia in rats 2023 ·Metabolic Brain Disease ·Maha Nasr, Omar A. Ahmed‐Farid, Rania F. Ahmed	8
12	Pterostilbene lipid nanocapsules as a promising system for treatment of hepatocellular carcinoma: Formulation, characterization, and cellular/in vivo appraisal 2023 ·Journal of Drug Delivery Science and Technology ·Sara A. Abdel Gaber, Maha Nasr, Mohamed A. Hamzawy	8
13	Preparation and characterization of mangiferin-loaded lipid nanocapsules 2023 ·(unknown), Maha Nasr, Nahed D. Mortada, (unknown)	1
14	Gold-Polypyrrole-Loaded Eosin in Photo-Mediated Treatment of Hidradenitis Suppurativa: In Vivo Trans-Epidermal Permeation Study and Clinical Case Report 2022 ·Pharmaceutics ·(unknown), Maha Fadel, Maha Nasr, Ibrahim M. El‐Sherbiny, Abeer Attia Tawfik, (unknown), Doaa Abdel Fadeel	1
15	Recent Formulation Advances of Mangiferin 2022 ·Revista Brasileira de Farmacognosia ·(unknown), Maha Nasr, Rania F. Ahmed, (unknown), Nahed D. Mortada	17
16	New repurposed rolapitant in nanovesicular systems for lung cancer treatment: Development, in-vitro assessment and in-vivo biodistribution study 2022 ·European Journal of Pharmaceutical Sciences ·(unknown), Maha Nasr, Ismail Ibrahim, Yasser A. Hassan, Ibrahim M. El‐Sherbiny	19
17	(Rose Bengal)/(Eosin Yellow)-Gold-Polypyrrole Hybrids: A Design for Dual Photo-Active Nano-System with Ultra-High Loading Capacity 2021 ·Drug Design Development and Therapy ·(unknown), Doaa Abdel Fadeel, Maha Nasr, Maha Fadel, Ibrahim M. El‐Sherbiny	3
18	Insightful exploring of advanced nanocarriers for the topical/transdermal treatment of skin diseases 2021 ·Pharmaceutical Development and Technology ·Ghada M. El-Zaafarany, Maha Nasr	15
19	Intranasally administered in situ gelling nanocomposite system of dimenhydrinate: preparation, characterization and pharmacodynamic applicability in chemotherapy induced emesis model 2017 ·Scientific Reports ·(unknown), Maha Nasr, Rania F. Ahmed, (unknown), Samar Mansour	45
20	Suitability of liposomal carriers for systemic delivery of risedronate using the pulmonary route 2013 ·Drug Delivery ·Maha Nasr, (unknown), Rania M. Hathout	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact